294 related articles for article (PubMed ID: 12244338)
21. Infection of mesothelial cells with human herpes virus 8 in human immunodeficiency virus-infected patients with Kaposi's sarcoma, Castleman's disease, and recurrent pleural effusions.
Bryant-Greenwood P; Sorbara L; Filie AC; Little R; Yarchoan R; Wilson W; Raffeld M; Abati A
Mod Pathol; 2003 Feb; 16(2):145-53. PubMed ID: 12591967
[TBL] [Abstract][Full Text] [Related]
22. Kaposi's sarcoma-associated herpesvirus-like DNA sequences (KSHV/HHV-8) in oral AIDS-Kaposi's sarcoma: a PCR and clinicopathologic study.
Flaitz CM; Jin YT; Hicks MJ; Nichols CM; Wang YW; Su IJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Feb; 83(2):259-64. PubMed ID: 9117759
[TBL] [Abstract][Full Text] [Related]
23. Distinct biology of Kaposi's sarcoma-associated herpesvirus from primary lesions and body cavity lymphomas.
Friborg J; Kong WP; Flowers CC; Flowers SL; Sun Y; Foreman KE; Nickoloff BJ; Nabel GJ
J Virol; 1998 Dec; 72(12):10073-82. PubMed ID: 9811747
[TBL] [Abstract][Full Text] [Related]
24. Human herpesvirus 8 (HHV-8) in the pathogenesis of Kaposi's sarcoma and other diseases.
Humphrey RW; Davis DA; Newcomb FM; Yarchoan R
Leuk Lymphoma; 1998 Jan; 28(3-4):255-64. PubMed ID: 9517497
[TBL] [Abstract][Full Text] [Related]
25. Genotypic and clinicopathological characterization of Kaposi's sarcoma-associated herpesvirus infection in Japan.
Kanno T; Sato Y; Nakamura T; Sakamoto K; Sata T; Katano H
J Med Virol; 2010 Mar; 82(3):400-6. PubMed ID: 20087946
[TBL] [Abstract][Full Text] [Related]
26. High seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV) among HIV-1-infected children and adolescents in a non-endemic population.
Feiterna-Sperling C; Königs C; Notheis G; Buchholz B; Krüger R; Weizsäcker K; Eberle J; Hanhoff N; Gärtner B; Heider H; Krüger DH; Hofmann J
Med Microbiol Immunol; 2016 Oct; 205(5):425-34. PubMed ID: 27240652
[TBL] [Abstract][Full Text] [Related]
27. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma.
Lebbé C; Blum L; Pellet C; Blanchard G; Vérola O; Morel P; Danne O; Calvo F
AIDS; 1998 May; 12(7):F45-9. PubMed ID: 9619797
[TBL] [Abstract][Full Text] [Related]
28. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.
Lennette ET; Blackbourn DJ; Levy JA
Lancet; 1996 Sep; 348(9031):858-61. PubMed ID: 8826812
[TBL] [Abstract][Full Text] [Related]
29. Insights into the molecular biology and sero-epidemiology of Kaposi's sarcoma.
Stebbing J; Portsmouth S; Bower M
Curr Opin Infect Dis; 2003 Feb; 16(1):25-31. PubMed ID: 12821826
[TBL] [Abstract][Full Text] [Related]
30. Signal transduction targets in Kaposi's sarcoma.
Sullivan R; Dezube BJ; Koon HB
Curr Opin Oncol; 2006 Sep; 18(5):456-62. PubMed ID: 16894293
[TBL] [Abstract][Full Text] [Related]
31. [Epidemiology of human herpes virus 8 (HHV-8) or the herpes virus associated with Kaposi's sarcoma (KSHV)].
Plancoulaine S; Abel L; Gessain A
Pathol Biol (Paris); 2002 Oct; 50(8):496-502. PubMed ID: 12469519
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12).
Muralidhar S; Veytsmann G; Chandran B; Ablashi D; Doniger J; Rosenthal LJ
J Clin Virol; 2000 May; 16(3):203-13. PubMed ID: 10738139
[TBL] [Abstract][Full Text] [Related]
33. Kaposi's sarcoma-associated herpesvirus transmission and primary infection.
Bagni R; Whitby D
Curr Opin HIV AIDS; 2009 Jan; 4(1):22-6. PubMed ID: 19339936
[TBL] [Abstract][Full Text] [Related]
34. Biology of Kaposi's sarcoma-associated herpesvirus.
Bryan BA; Dyson OF; McCubrey JA; Akula SM
Front Biosci; 2005 Sep; 10():2882-91. PubMed ID: 15970542
[TBL] [Abstract][Full Text] [Related]
35. Kaposi's sarcoma and other manifestations of human herpesvirus 8.
Geraminejad P; Memar O; Aronson I; Rady PL; Hengge U; Tyring SK
J Am Acad Dermatol; 2002 Nov; 47(5):641-55; quiz 656-8. PubMed ID: 12399755
[TBL] [Abstract][Full Text] [Related]
36. Intrafamiliar transmission of Kaposi's sarcoma-associated herpesvirus and seronegative infection in family members of classic Kaposi's sarcoma patients.
Mancuso R; Brambilla L; Agostini S; Biffi R; Hernis A; Guerini FR; Agliardi C; Tourlaki A; Bellinvia M; Clerici M
J Gen Virol; 2011 Apr; 92(Pt 4):744-51. PubMed ID: 21216985
[TBL] [Abstract][Full Text] [Related]
37. Restricted tissue distribution of extralesional Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS patients with Kaposi's sarcoma.
Corbellino M; Poirel L; Bestetti G; Pizzuto M; Aubin JT; Capra M; Bifulco C; Berti E; Agut H; Rizzardini G; Galli M; Parravicini C
AIDS Res Hum Retroviruses; 1996 May; 12(8):651-7. PubMed ID: 8744575
[TBL] [Abstract][Full Text] [Related]
38. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients.
Dictor M; Rambech E; Way D; Witte M; Bendsöe N
Am J Pathol; 1996 Jun; 148(6):2009-16. PubMed ID: 8669485
[TBL] [Abstract][Full Text] [Related]
39. [Human herpesvirus 8 (HHV-8): clinical and epidemiological aspects and clonality of associated tumors].
Gessain A
Bull Acad Natl Med; 2008; 192(6):1189-204; discussion 1204-6. PubMed ID: 19235482
[TBL] [Abstract][Full Text] [Related]
40. Human herpesvirus 8: serovprevalence and correlates in tumor patients from Xinjiang, China.
He F; Wang X; He B; Feng Z; Lu X; Zhang Y; Zhao S; Lin R; Hui Y; Bao Y; Zhang Z; Wen H
J Med Virol; 2007 Feb; 79(2):161-6. PubMed ID: 17177299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
